title: Immunogenicity, immunosensitivity and cell surface adhesiveness of tumour vaccines carrying an inserted CD80 gene.
abstract: Cell surface adhesiveness, immunogenicity and immunosensitivity of tumour vaccines modified by the CD80 gene transfection was examined and compared to that of the parental MC12 murine sarcoma. Insertion of the CD80 gene substantially enhanced the adhesiveness of the genetically modified tumour cells to nylon wool non-adherent (T) but not to nylon wool adherent (B) lymphocytes. The increased adhesive interaction could be inhibited by anti-CD80 monoclonal antibody. CD80+ transfectants were more sensitive to the cytotolytic effect of MC12-immune splenocytes and IL-2-activated spleen cells than the parental MC12 sarcoma. Similarly, spleen cells from syngeneic mice immunized with CD80+ transfectants displayed a higher cytolytic activity when allowed to react with MC12 cells than splenocytes from mice immunized with the parental MC12 cells. These results suggest that a positive correlation exists among the expression of the CD80 molecules, T cell adhesion to the genetically modified cells, immunosensitivity of the CD80+ transfectants and the capacity of the transfectants to activate cytolytic, tumour-reactive effector cells in vivo. This correlation provides a rationale for gene therapy based on the construction of CD80- modified tumour vaccines.
authors.affiliation: Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Flemingovo nam. 2, 166 37 Prague 6, Czech Republic.
authors.forename: M
authors.initials: M
authors.lastname: Indrova
authors.forename: J
authors.initials: J
authors.lastname: Bubenik
authors.forename: P
authors.initials: P
authors.lastname: Rossner
authors.forename: J
authors.initials: J
authors.lastname: Zeuthen
authors.forename: T
authors.initials: T
authors.lastname: Jandlova
authors.forename: V
authors.initials: V
authors.lastname: Sobota
mesh_terms: D000818:Animals; D018122:B7-1 Antigen / Q000235:genetics*; D019496:Cancer Vaccines / Q000235:genetics / Q000276:immunology*; D002448:Cell Adhesion; D004195:Disease Models, Animal; D005260:Female; D015316:Genetic Therapy; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000502:physiology; D051379:Mice; D008815:Mice, Inbred Strains; D012513:Sarcoma, Experimental / Q000276:immunology / Q000503:physiopathology*; D013154:Spleen / Q000502:physiology; D013601:T-Lymphocytes / Q000502:physiology*; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000502:physiology
chemical_list: D018122:B7-1 Antigen; D019496:Cancer Vaccines; D007376:Interleukin-2